Through a new advertising campaign being launched in US, local women will soon learn more about cervical cancer screening and prevention.
Cervical cancer is caused by high-risk types of the human papillomavirus (HPV) and QIAGEN, the maker of the only FDA-approved HPV test, has selected Memphis as a priority market for a new campaign to air its 30-second ad for the digene HPV Test on local TV stations starting today through April 20.
QIAGEN chose Memphis based on market research data that revealed only 32 percent of eligible women in the region were receiving the HPV DNA test despite the city having a large female population over age 30, strong insurance coverage and access to the latest in cervical screening technology.
Additionally, results from a Women in Government (WIG) state assessment of cervical cancer prevention signaled the need for further concentration: Tennessee received only a “fair” rating (9 out of 22 measured data points) in WIG’s “Turning Challenges Into Opportunities: The ‘State’ of Cervical Cancer Prevention in America 2008.” Women in Government is a national, non-profit, bi-partisan organization of women state legislators.
“Our goal is to educate Memphis women about the cause of cervical cancer – high-risk types of the HPV virus – and inform women that with proper screening, cervical cancer is preventable,” said Jeff Schmalz, QIAGEN’s Director of Molecular Diagnostic Marketing for the Americas. “Through this local ad campaign, we hope to encourage more conversations between women and their doctors or nurses about cervical cancer prevention. Our TV ad shows that combining the HPV test with the Pap smear in women over 30, who are most at risk for cervical cancer, provides the highest level of protection.”
“Unlike virtually all other types of cancer, we know the specific cause of cervical cancer and can test for it. If a woman has a normal Pap smear, but is shown to have high-risk types of HPV, we can know that she is in a higher-risk group and she can be monitored closely to ensure that cervical disease or cancer is not missed,” said Dr. Joseph Santoso from West Clinic in Memphis. “Offering the HPV test underscores our commitment to providing our patients the most accurate, state-of-the-art screening techniques available. With HPV testing, we can now know a woman’s HPV status. It’s similar to knowing your cholesterol levels, which most people now accept as a routine way of assessing risk of potential heart disease, so that they can take action when necessary. In the same way, HPV status can help women and their clinicians assess risk for cervical disease, and enable early preventative action.” With more than 40 physicians across a range of specialties, nurses and nurse practitioners in more than seven Memphis area locations, West Clinic offers a combination of cervical cancer prevention tools, including Pap testing, HPV screening and HPV vaccination – depending on a woman’s age.
Source: QIAGEN, USA
- « Gardasil approval delayed for use in women ages 27 – 45
- Cervical Cancer
- Cervical cancer screening might safely be delayed after HPV vaccine »
Editor Health NewsTV ad to educate women about cervical cancer and HPV test
by Editor Health News ( Author at Health Newstrack )
Posted on February 10th, 2009 at 9:27 am.
Track Health News on: Cervical Cancer